BACKGROUND: Current traditional pathological parameters, including staging and grading, are not sufficient in predicting outcome in patients with renal cell carcinoma (RCC). Acrogranin is an epithelial growth factor and has been demonstrated to play a role in teratocarcinogenesis and tumorigenesis. The aim of this study was to examine levels of acrogranin in renal cancer. MATERIALS AND METHODS: Western blot analysis was performed on renal tissue protein lysates. In addition, immunohistochemical (IHC) analysis of acrogranin expression was conducted on tissue sections of various histological types and grades of RCC. RESULTS: Western analysis showed that acrogranin levels were low in benign renal tissue and increased in malignant renal tissue. In addition, IHC revealed that high-grade RCC exhibited higher levels of expression than low-grade RCC and normal tissue. CONCLUSION: These data suggest that acrogranin may be a functional important growth factor in RCC and may be a potential molecular marker for high-grade RCC.
BACKGROUND: Current traditional pathological parameters, including staging and grading, are not sufficient in predicting outcome in patients with renal cell carcinoma (RCC). Acrogranin is an epithelial growth factor and has been demonstrated to play a role in teratocarcinogenesis and tumorigenesis. The aim of this study was to examine levels of acrogranin in renal cancer. MATERIALS AND METHODS: Western blot analysis was performed on renal tissue protein lysates. In addition, immunohistochemical (IHC) analysis of acrogranin expression was conducted on tissue sections of various histological types and grades of RCC. RESULTS: Western analysis showed that acrogranin levels were low in benign renal tissue and increased in malignant renal tissue. In addition, IHC revealed that high-grade RCC exhibited higher levels of expression than low-grade RCC and normal tissue. CONCLUSION: These data suggest that acrogranin may be a functional important growth factor in RCC and may be a potential molecular marker for high-grade RCC.
Authors: John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson Journal: J Mol Biol Date: 2010-08-01 Impact factor: 5.469
Authors: Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas Journal: Mol Biosyst Date: 2011-02-11
Authors: Wang-Xia Wang; Bernard R Wilfred; Sindhu K Madathil; Guiliang Tang; Yanling Hu; James Dimayuga; Arnold J Stromberg; Qingwei Huang; Kathryn E Saatman; Peter T Nelson Journal: Am J Pathol Date: 2010-05-20 Impact factor: 4.307
Authors: Amro M S El-Ghammaz; Mohamed O Azzazi; Nevine Mostafa; Hany M Hegab; Amir A Mahmoud Journal: Clin Exp Med Date: 2020-01-31 Impact factor: 3.984
Authors: Fabian Arechavaleta-Velasco; Carlos Eduardo Perez-Juarez; George L Gerton; Laura Diaz-Cueto Journal: Med Oncol Date: 2017-11-07 Impact factor: 3.064
Authors: Dmitri Tolkatchev; Suneil Malik; Anna Vinogradova; Ping Wang; Zhigang Chen; Ping Xu; Hugh P J Bennett; Andrew Bateman; Feng Ni Journal: Protein Sci Date: 2008-04 Impact factor: 6.725
Authors: Ramouna Voshtani; Mei Song; Huan Wang; Xiaoqi Li; Wei Zhang; Mojdeh S Tavallaie; Wenjun Yan; Joseph Sun; Fang Wei; Xiaojing Ma Journal: Cancer Lett Date: 2019-09-03 Impact factor: 8.679
Authors: Cara L Ryan; David C Baranowski; Babykumari P Chitramuthu; Suneil Malik; Zhi Li; Mingju Cao; Sandra Minotti; Heather D Durham; Denis G Kay; Christopher A Shaw; Hugh P J Bennett; Andrew Bateman Journal: BMC Neurosci Date: 2009-10-27 Impact factor: 3.288